From: The Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding Chambers
Distribution | |||
---|---|---|---|
Variable | Total | Strata | P |
Age (yr) | 43.10 ± 12.99 | Male: 44.93 ± 14.07 Female: 43.32 ± 12.56 | 0.71 |
Gender | N = 40 | Male: 15 Female: 25 | NA |
Weight (kg) | 68.53 ± 13.38 | Male: 73.27 ± 9.26 Female: 65.68 ± 14.79 | 0.08 |
Height (cm) | 163.33 ± 7.91 | Male: 170.45 ± 7.70 Female: 159.04 ± 4.00 | < 0.0001* |
FVC† difference‡ | 5.34 ± 7.45 | Asthm Yar: 4.75 ± 6.99 Dam Yar: 6.05 ± 8.00 | 0.46 |
FEV1† difference‡ | 7.39 ± 5.49 | Asthm Yar: 7.54 ± 5.08 Dam Yar: 7.23 ± 5.93 | 0.53 |
PEF† difference‡ | 4.18 ± 13.52 | Asthm Yar: 7.10 ± 13.64 Dam Yar: 1.25 ± 12.92 | 0.054 |
FEF25-75%† difference‡ | 16.20 ± 12.49 | Asthm Yar: 16.30 ± 12.05 Dam Yar: 16.10 ± 13.06 | 0.92 |
FEF50%† difference‡ | 13.94 ± 11.55 | Asthm Yar: 13.45 ± 11.78 Dam Yar: 14.43 ± 11.44 | 0.64 |
Preference | 6.00 ± 2.58 | Asthm Yar: 4.83 ± 2.38 Dam Yar: 7.18 ± 2.23 | < 0.0001* |
SUC (ng/mL)§ | Mean: 1057.76 ± 437.86 | Asthm Yar Mean: 1188.84 ± 478.80 Minimum: 419.51 Maximum: 2471.95 Dam Yar Mean: 926.68 ± 351.95 Minimum: 264.63 Maximum: 1787.81 | 0.002* |